COPENHAGEN, May 6 () - Novo Nordisk, the maker of weight-loss drug Wegovy, on Wednesday reported first-quarter revenue and adjusted operating profit above expectations and said its outlook for the year was slightly improved. The Danish drugmaker is banking on demand for its new weight-loss pill as competition with U.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
58last 24h
975last 7d
109● bullish (7d)
123● bearish (7d)
212publishers
Reuters136d agobullish
Novo Nordisk slightly raises outlook as first-quarter profit beats forecastInvestor's Business Daily162d agobullish
These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; AI-Related Stocks ReboundAmong the best stocks in earnings performance, Comfort Systems has a pristine 99 EPS Rating, the highest in IBD's air conditioning and heating products industry group.